DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR
Delivery Order · National Institutes of Health · to Leidos Biomedical Research Inc (UEI HV8BH9BPG8Y9) · data as of 2026-09-30
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
14 subawards totaling $93.99M (186.7% of what was obligated), as Leidos Biomedical Research Inc reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
THE SUBCONTRACTOR, AS THE KEY IMPLEMENTATION PARTNER IN THE DEMOCRATIC REPUBLIC OF CONGO (DRC), SHALL BE RESPONSIBLE FOR PROVIDING THE PREPARATION, IMPLEMENTATION AND EXECUTION FOR CLINICAL OPERATION ACTIVITIES…
2024-03-21
Mitchell Group, Inc. (The)
$21.94M
THE SUBCONTRACTOR, AS THE KEY IMPLEMENTATION PARTNER IN THE DEMOCRATIC REPUBLIC OF CONGO (DRC), SHALL BE RESPONSIBLE FOR PROVIDING THE PREPARATION, IMPLEMENTATION AND EXECUTION FOR CLINICAL OPERATION ACTIVITIES…
2023-08-31
Mitchell Group, Inc. (The)
$20.25M
THE SUBCONTRACTOR, AS THE KEY IMPLEMENTATION PARTNER IN THE DEMOCRATIC REPUBLIC OF CONGO DRC, SHALL BE RESPONSIBLE FOR PROVIDING THE PREPARATION, IMPLEMENTATION AND EXECUTION FOR CLINICAL OPERATION ACTIVITIES…
2023-07-28
Mitchell Group, Inc. (The)
$12.44M
THE SUBCONTRACTOR WILL BE TASKED TO SUPPORT ALL ASPECTS OF THE INVITE PROTOCOL. THE INVITE PROTOCOL IS A MULTICENTER STUDY OF COVID 19 VACCINE IMMUNOGENICITY, DURABILITY, AND BREAKTHROUGH SEVERE ACUTE RESPIRATORY…
Every action
7 actions since 2023-08-17. Each is a modification or amendment with the money it added or took back.
Date
Modification
Kind
Amount
What the agency wrote
2025-09-24
P00013
Funding only
$8.35M
EOI: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI.
2025-04-24
P00012
Terminated for convenience
$0
EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI.
2025-01-07
P00011
Administrative change
$0
DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR
2024-08-26
P00010
Administrative change
$2.14M
DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR
2024-08-09
P00009
Terminated for convenience
-$7.71M
DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR
2023-09-22
P00008
Option exercised
$34.47M
DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR
2023-08-17
P00007
Administrative change
$13.09M
DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗
2025-01-14
Regents of the University of Minnesota
$8.29M
MS4 OPT2 - STUDY 3
2023-01-13
Mitchell Group, Inc. (The)
$2.00M
THE SUBCONTRACTOR WILL BE TASKED TO SUPPORT ALL ASPECTS OF THE INVITE PROTOCOL. THE INVITE PROTOCOL IS A MULTICENTER STUDY OF COVID-19 VACCINE IMMUNOGENICITY, DURABILITY, AND BREAKTHROUGH SEVERE ACUTE RESPIRATORY…
2024-09-30
Mitchell Group, Inc. (The)
$1.54M
THE SUBCONTRACTOR SHALL PROVIDE ALL RESOURCES REQUIRED TO MAINTAIN THE UCRC CORE CLINICAL RESEARCH
INFRASTRUCTURE WARM BASE CLINICAL RESEARCH CENTER AND RESEARCH LAB FACILITIES. THE SUBCONTRACTOR IS TO PROVIDE…
2023-08-31
Mitchell Group, Inc. (The)
$1.15M
UNDER LEIDOS BIOMED SUBCONTRACT 21X175Q2 THE SUBCONTRACTOR WILL BE TASKED TO SUPPORT ALL ASPECTS OF THE UCRC INVITE AND MEASLES PROTOCOLS, INCLUDING: HUMAN RESOURCES MANAGEMENT, ACCOUNTING AND FINANCIAL MANAGEMENT,…
2023-07-17
Mitchell Group, Inc. (The)
$647.8K
SUBCONTRACTOR WILL BE TASKED TO SUPPORT ALL ASPECTS OF THE INVITE STUDY AND THE MEASLES STUDY AS FURTHER OUTLINED IN THE SOW. THE INVITE PROTOCOL IS A MULTICENTER STUDY OF COVID 19 VACCINE IMMUNOGENICITY AND…
2023-03-17
Mitchell Group, Inc. (The)
$327.8K
THE SUBCONTRACTOR WILL BE TASKED TO SUPPORT ALL ASPECTS OF THE INVITE PROTOCOL. THE INVITE PROTOCOL IS A MULTICENTER STUDY OF COVID-19 VACCINE IMMUNOGENICITY, DURABILITY, AND
BREAKTHROUGH SEVERE ACUTE RESPIRATORY…
2025-08-31
Mitchell Group, Inc. (The)
$217.4K
THE SUBCONTRACTOR SHALL PROVIDE ALL RESOURCES REQUIRED TO MAINTAIN THE UCRC CORE CLINICAL RESEARCH
INFRASTRUCTURE WARM BASE CLINICAL RESEARCH CENTER AND RESEARCH LAB FACILITIES. THE SUBCONTRACTOR IS TO PROVIDE…
2025-08-31
Mitchell Group, Inc. (The)
$213.3K
MEASLES SUPPORT TO THE PREGUI PROGRAM.
2026-02-03
Regents of the University of California, San Francisco, the
$93.8K
SUBJECT MATTER EXPERTISE TO SERVE AS THE CLINICAL LEAD SCIENTIST FOR STRATEGIES AND TREATMENT FOR RESPIRATORY INFECTIONS AND VIRAL EMERGENCIES (STRIVE) METAGENOMICS WORK.
2023-07-07
Mitchell Group, Inc. (The)
$63.4K
THE PROJECT REQUIREMENT IS TO MANAGE THE RESOURCES NEEDED TO SUPPORT UCRC IN THE CONDUCT OF CLINICAL RESEARCH ACTIVITIES. THE SUBCONTRACTOR SHALL ENSURE THAT THE DELIVERABLES IN THE SOW ARE ACHIEVED.
SERVICES TO…
75N91020F00025: DCR Is Requesting the Services of Leidos Biomedical Research, Inc.… · SpendQuery